Patents by Inventor Jong Pil Min

Jong Pil Min has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9249109
    Abstract: The present invention relates to an improved method for preparing dipeptidyl peptidase-IV inhibitor intermediates. The present invention is able to reduce preparation costs by using low cost reagents on reaction and is able to be used in mass production by improving yield.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: February 2, 2016
    Assignee: DONG-A PHARMACEUTICAL CO., LTD.
    Inventors: Woo Young Kwak, Heung Jae Kim, Jong Pil Min, Tae Hyun Yoon, Moohi Yoo, Geun Gho Lim, Sun Ki Chang
  • Publication number: 20150025241
    Abstract: The present invention relates to an improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention is able to reduce preparation costs by using low cost reagents on reaction and is able to be used in mass production by improving yield.
    Type: Application
    Filed: October 3, 2014
    Publication date: January 22, 2015
    Inventors: Woo Young KWAK, Heung Jae KIM, Jong Pil MIN, Tae Hyun YOON, Moohi YOO, Geun Gho LIM, Sun Ki CHANG
  • Patent number: 8598347
    Abstract: The present invention relates to an improved method for manufacturing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention allows reduction of production costs by reacting low cost reagents, improves yield and is adaptable for mass production.
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: December 3, 2013
    Assignee: Dong-A Pharmaceutical. Co., Ltd
    Inventors: Woo Young Kwak, Heung Jae Kim, Jong Pil Min, Tae Hyun Yoon, Hyun Joo Shim, Moohi Yoo
  • Patent number: 8440669
    Abstract: The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetes or obesity comprising as active ingredients a compound which inhibits the activity of dipeptidyl peptidase-IV (DPP-IV), a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and one or more other antidiabetic or antiobesity agents. The pharmaceutical composition exhibits excellent glucose tolerance and may be useful in the prevention and treatment of diabetes, obesity, and the like by effectively inhibiting blood glucose levels and reducing fat mass.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: May 14, 2013
    Assignee: Dong-A Pharmaceutical Co. Ltd.
    Inventors: Chang Yell Shin, Song-Hyen Choi, Yu Na Chae, Eun Kyoung Yang, Gook Jun Ahn, Moon-Ho Son, Heung Jae Kim, Woo Young Kwak, Jong Pil Min, Tae Hyun Yoon, Soon Hoe Kim, Moohi Yoo
  • Publication number: 20120016125
    Abstract: The present invention relates to an improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention is able to reduce preparation costs by using low cost reagents on reaction and is able to be used in mass production by improving yield.
    Type: Application
    Filed: March 30, 2010
    Publication date: January 19, 2012
    Applicant: DONG-A PHARMACEUTICAL. CO., LTD
    Inventors: Woo Young Kwak, Heung Jae Kim, Jong Pil Min, Tae Hyun Yoon, Moohi Yoo, Geun Gho Lim, Sun Ki Chang
  • Publication number: 20120016126
    Abstract: The present invention relates to an improved method for manufacturing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention allows reduction of production costs by reacting low cost reagents, improves yield and is adaptable for mass production.
    Type: Application
    Filed: March 30, 2010
    Publication date: January 19, 2012
    Applicant: DONG-A PHARMACEUTICAL. CO., LTD
    Inventors: Woo Young Kwak, Heung Jae Kim, Jong Pil Min, Tae Hyun Yoon, Hyun Joo Shim, Moohi Yoo
  • Patent number: 8030315
    Abstract: The present invention provides a novel heterocyclic compound containing a beta-amino group, a method for preparing the same, and a pharmaceutical composition comprising the same heterocyclic compound or a pharmaceutically acceptable salt thereof as an active ingredient. The heterocyclic compound of the present invention exhibits excellent DPP-IV inhibitory activity and bioavailability and therefore can be useful for the prophylaxis or treatment of DPP-IV-related diseases such as diabetes or obesity.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: October 4, 2011
    Assignee: Dong-A Pharm. Co., Ltd.
    Inventors: Heung Jae Kim, Woo Young Kwak, Chang Yell Shin, Hadong Kim, Jong Pil Min, Kyung Jin Park, Jae Young Lee, Song-Hyen Choi, Tae Hyun Yoon, Hae-Sun Kim, Ji Myun Jang, Mi-Kyung Kim, Moon-Ho Son, Soon Hoe Kim, Moohi Yoo
  • Publication number: 20110201624
    Abstract: The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetes or obesity comprising as active ingredients a compound which inhibits the activity of dipeptidyl peptidase-IV (DPP-IV), a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and one or more other antidiabetic or antiobesity agents. The pharmaceutical composition exhibits excellent glucose tolerance and may be useful in the prevention and treatment of diabetes, obesity, and the like by effectively inhibiting blood glucose levels and reducing fat mass.
    Type: Application
    Filed: October 16, 2009
    Publication date: August 18, 2011
    Applicant: DONG-A PHARMACEUTICAL. CO., LTD
    Inventors: Chang Yell Shin, Song-Hyen Choi, Yu Na Chae, Eun Kyoung Yang, Gook Jun Ahn, Moon-Ho Son, Heung Jae Kim, Woo Young Kwak, Jong Pil Min, Tae Hyun Yoon, Soon Hoe Kim, Moohi Yoo
  • Publication number: 20100120790
    Abstract: The present invention provides a novel heterocyclic compound containing a beta-amino group, a method for preparing the same, and a pharmaceutical composition comprising the same heterocyclic compound or a pharmaceutically acceptable salt thereof as an active ingredient. The heterocyclic compound of the present invention exhibits excellent DPP-IV inhibitory activity and bioavailability and therefore can be useful for the prophylaxis or treatment of DPP-IV-related diseases such as diabetes or obesity.
    Type: Application
    Filed: April 18, 2008
    Publication date: May 13, 2010
    Applicant: DONG-A PHARM. CO., LTD
    Inventors: Heung Jae Kim, Woo Young Kwak, Chang Yell Shin, Hadong Kim, Jong Pil Min, Kyung Jin Park, Jae Young Lee, Song-Hyen Choi, Tae Hyun Yoon, Hae-Sun Kim, Ji Myung Jang, Mi-Kyung Kim, Moon-Ho Son, Soon Hoe Kim, Moohi Yoo